DUBLIN--(BUSINESS WIRE)--The "Global Oncology Information System Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Oncology Information System Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include rising availability of a variety of cancer therapies, like chemotherapy and radiation therapy, increase in technological advancements like, incorporation of patient portals and increasing initiatives related to modernization of healthcare infrastructure.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.
With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
This report provides data tables, includes charts and graphs for visual analysis.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments
Key Topics Covered
1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Rising Availability of a Variety of Cancer Therapies, like Chemotherapy and Radiation Therapy
3.1.2 Increase in Technological Advancements like, Incorporation of Patient Portals
3.1.3 Increasing Initiatives Related to Modernization of Healthcare Infrastructure
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
4 Oncology Information System Market, By Products & Services
4.1 Professional Services
4.1.1 Implementation Services
4.1.2 Consulting/Optimization Services
4.1.3 Post-Sale and Maintenance Services
4.2.1 Treatment Planning Systems
4.2.2 Patient Information Systems
5 Oncology Information System Market, By Application
5.1 Surgical Oncology
5.2 Medical Oncology
5.3 Radiation Oncology
6 Oncology Information System Market, By End User
6.1 Government Institutions
6.2 Hospitals & Physicians Offices
6.3 Research Centers
6.4 Oncology Clinics
7 Oncology Information System Market, By Geography
7.1 North America
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Middle East
7.4.1 Saudi Arabia
7.4.3 Rest of Middle East
7.5 Latin America
7.5.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 South Africa
8 Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Ventures, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
9.1 McKesson Corporation
9.2 Cerner Corporation
9.3 Epic Systems Corporation
9.4 Koninklijke Philips N.V.
9.5 Bogardus Medical Systems Inc.
9.6 Accuray Incorporated
9.7 Flatiron Health Inc.
9.8 Elekta AB
9.9 CureMD Corporation
For more information about this report visit https://www.researchandmarkets.com/r/e81ro7